Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden

Laura Di Domenico,Yair Goldberg,Vittoria Colizza

DOI: https://doi.org/10.1101/2024.03.08.24303201

2024-03-10

Abstract:As public health policies shifted in 2023 from emergency response to long-term COVID-19 disease management, immunization programs started to face the challenge of formulating routine booster campaigns in a still highly uncertain seasonal behavior of the COVID-19 epidemic. Mathematical models assessing past booster campaigns and integrating knowledge on waning of immunity can help better inform current and future vaccination programs. Focusing on the first booster campaign in the 2021/2022 winter in France, we used a multi-strain age-stratified transmission model to assess the effectiveness of the observed booster vaccination in controlling the succession of Delta, Omicron BA.1 and BA.2 waves. We explored counterfactual scenarios altering the eligibility criteria and inter-dose delay. Our study showed that the success of the immunization program in curtailing the Omicron BA.1 and BA.2 waves was largely dependent on the inclusion of adults among the eligible groups, and was highly sensitive to the inter-dose delay, which was changed over time. Shortening or prolonging this delay, even by only one month, would have required substantial social distancing interventions to curtail the hospitalization peak. Also, the time window for adjusting the delay was very short. Our findings highlight the importance of readiness and adaptation in the formulation of routine booster campaign in the current level of epidemiological uncertainty.

Infectious Diseases (except HIV/AIDS)

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to reduce the disease burden by adjusting the vaccination strategy during the COVID - 19 booster vaccination campaign in France in the winter of 2021 - 2022. Specifically, the study focused on the following aspects:

1. **Impact of vaccination time**: The study evaluated the effects of different vaccination intervals (i.e., the time interval between the second dose and the booster dose) on controlling the Delta, Omicron BA.1 and BA.2 epidemic waves. In particular, it explored the impact of shortening or lengthening the vaccination interval on the peak of hospital admissions.

2. **Selection of target population**: The study analyzed the effect of expanding the eligibility for booster vaccination to the adult population (19 - 64 years old) rather than limiting it to the elderly (65 years old and above). This involves the role of different age groups in the epidemic spread and their impact on the vaccination strategy.

3. **Importance of adaptive vaccination strategies**: The study also explored the possibility and necessity of rapidly adjusting the vaccination strategy during the evolution of the epidemic. For example, after the discovery of a new variant, how to quickly adjust the vaccination interval to respond to the upcoming epidemic wave.

4. **Need for non - pharmaceutical interventions**: The study evaluated whether additional social distancing measures (such as reducing social contacts) were required to control the epidemic under different vaccination strategies, especially when the vaccine protection waned.

Through these analyses, the paper aims to provide a scientific basis for future routine booster vaccination programs, especially on how to develop more flexible and effective vaccination strategies in the face of a constantly changing epidemic environment.